NCT00835172View on ClinicalTrials.gov

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Glimepiride 4 mg Tablets

1 x 4 mg, single-dose non-fasting

DRUG

AMARYL® 4 mg Tablets

1 x 4 mg, single-dose non-fasting

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835172 - Glimepiride 4 mg Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter